regarding

SMC Announces Marketing Agreement with Plato Technologies. Inc.

Source Node:
Time Stamp: April 19, 2024 5:45 AM - Modified On: April 19, 2024 - Published By:
Source Cluster:
Republished By Plato

  BOCA RATON, FL / Plato / Amplifi / April 18,2024 / SMC Entertainment, Inc. ("SMC" or the "Company") (OTC PINK: SMCE) SMC / (PINK:SMCE) is pleased to announce a marketing agreement and collaboration with Plato Technologies Inc. Plato Technologies specializes in AI content disruption and AI management systems. The collaboration will enable the Company to market Plato's platform directly to web and content development teams. The companies have agreed on a revenue sharing agreement after deducting individual client acquisition costs. "This is just the beginning." stated Erik Blum CEO

Hard Forks, Soft Forks, Defaults and Coercion

Source Node:
Time Stamp: February 20, 2024 1:15 PM - Modified On: February 20, 2024 - Published By:
Source Cluster:
Republished By Plato

One of the important arguments in the blockchain space is that of whether hard forks or soft forks are the preferred protocol upgrade mechanism. The basic difference between the two is that soft forks change the rules of a protocol by strictly reducing the set of transactions that is valid, so nodes following the old rules will still get on the new chain (provided that the majority of miners/validators implements the fork), whereas hard forks allow previously invalid transactions and blocks to become valid, so clients must upgrade their clients

Latest Survey from Sotera Digital Reveals Shocking State of Mobile Phone Security in the Workplace.

Source Node:
Time Stamp: February 5, 2024 8:19 AM - Modified On: February 5, 2024 - Published By:
Source Cluster:
Republished By Plato

February 5, 2024, New York - Sotera Digital Security, a leading US based provider of secure communications solutions, has today released its findings from a survey it conducted among over 1,000 senior personnel of large businesses and multinational corporations across the globe. Sectors covered by the survey participants focused on those that require the need for ultra-secure and private communications - both regionally and worldwide - with clients, colleagues and suppliers; namely legal, pharmaceutical, media and corporate affairs, government, and blockchain / AI tech specialists. The survey results provide key

Bozo.Finance. A Groundbreaking NFTxTOKEN Solution Revolutionizing Decentralized Finance.

Source Node:
Time Stamp: February 1, 2024 10:47 AM - Modified On: February 1, 2024 - Published By:
Source Cluster:
Republished By Plato

  Bozo.Finance / Bozo Hybrid In an innovative leap forward for the DeFi space, Bozo Hybrid announces the launch of its revolutionary platform - a first-of-its-kind NFTxTOKEN hybrid that is reshaping the landscape of liquidity and asset interchangeability. The Game-Changing Innovation of Bozo HYBRID Bozo HYBRID is not just another project in the blockchain space. It represents a paradigm shift, a true DeFi 2.0 model, by integrating non-fungible tokens (NFTs) with fungible tokens ($bozo tokens) to create a two-way liquidity portal. This hybrid approach is a breakthrough in the market,

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Source Node:
Time Stamp: October 24, 2023 11:54 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:16 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

Bridging Real and Virtual Economies

Source Node:
Time Stamp: July 11, 2023 3:41 PM - Modified On: July 11, 2023 - Published By:
Source Cluster:
Republished By Plato

In an era where decentralized finance (DeFi) promises revolutionary, permissionless, and credit-check-free access to financial services, the limitations to its application lie in the narrow range of digital assets it encompasses. But industry pioneers are working to widen its scope by introducing real-world assets (RWAs) to the digital realm. For instance, in collaboration with the Hong Kong Monetary Authority (HKMA), Ripple is embarking on a research project to try and tokenize real estate. This venture was made public about seven weeks ago as part of a broader initiative, the digital

The Fight for Financial Freedom

Source Node:
Time Stamp: July 10, 2023 5:31 AM - Modified On: July 10, 2023 - Published By:
Source Cluster:
Republished By Plato

As the grasp of regulators tightens on the global cryptocurrency market, exchanges such as KuCoin are being compelled to implement mandatory pre-purchase checks. In tandem, several prominent banks are limiting funds transferred to cryptocurrency exchanges under the guise of protecting customers from fraudulent activities. In the background, the Financial Action Task Force (FATF) is looming over these rapidly evolving regulations. The FATF underscores the significance of Know Your Customer (KYC), Know Your Business (KYB), Know Your Transaction (KYT), and Anti-Money Laundering (AML) regulations applicable to all financial transactions, cryptocurrencies included.

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Source Node:
Time Stamp: June 7, 2023 12:21 PM - Modified On: June 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating

Moonstake Strengthens Executive Board with Appointment of CMO Pietro Curto

Source Node:
Time Stamp: November 15, 2022 6:11 AM - Modified On: November 15, 2022 - Published By:
Source Cluster:
Republished By Plato

SINGAPORE, Nov 15, 2022 - (ACN Newswire) - We are pleased to announce that we have strengthened our management with the appointment of CMO Pietro Curto. Pietro is a true veteran in digital marketing, with over 10 years of professional work in key areas such as acquisition, customer relationship management, digital strategies for retail customers, and operations. He also possesses deep expertise in regulated markets, having led FTSE listed companies such as Entain. With years of experience in such fast-paced international digital markets, Pietro was a perfect fit for the rapidly growing crypto market

Verseon Acquires Edammo to Deepen Drug Discovery Approach

Source Node:
Time Stamp: November 13, 2022 3:46 AM - Modified On: November 17, 2022 - Published By:
Source Cluster:
Republished By Plato

Published: Nov 12th, 2022 | By Mark Terry Verseon Corporation has acquired Edammo, an artificial intelligence-focused company, to deepen its own AI-based drug discovery platform, the companies revealed Tuesday. Adityo Prakash, co-founder and CEO of Verseon and Ed Ratner, CEO at Edammo, discussed the acquisition with BioSpace. “We develop completely new drugs on the computer, atom by atom, then we make them in the laboratory,” Prakash said. "We’re changing how small molecule drugs are designed and developed with a level of efficiency that hasn’t been possible before.” He added that

Bitsoft360 – the quality auto trading platform for cryptos

Source Node:
Time Stamp: September 23, 2022 5:45 AM - Modified On: September 23, 2022 - Published By:
Source Cluster:
Republished By Plato

Have you ever wondered which auto trading platform is the best for auto trading right now? What features of a high-quality platform provide excellent opportunities for profit in the volatile crypto market? One such platform has attracted huge attention from motivated crypto traders is the famous Bitsoft360 platform. Thanks to it, more than 520,000 active users worldwide have excellent trading opportunities and opportunities to increase their daily trading income significantly. To adequately understand the advantages of such an auto trading platform, you must understand all the basics and its undeniable